ACRX insider filings
ACELRX PHARMACEUTICALS INC — 14 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-12-14. Screen ACRX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ACRX between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — ACELRX PHARMACEUTICALS INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-12-14 | 4 | Angotti Vincent J. — Chief Executive Officer, Director | Purchase (P): 10,000 @ $0.73 | EDGAR |
| 2023-12-13 | 4 | Afable Richard — Director | Grant/award (A): 581 @ $0 · Grant/award (A): 3,487 (derivative) @ $0 | EDGAR |
| 2023-12-13 | 4 | Bozilenko Marina — Director | Grant/award (A): 581 @ $0 · Grant/award (A): 3,487 (derivative) @ $0 | EDGAR |
| 2023-12-13 | 4 | Rosen Howard B — Director | Grant/award (A): 581 @ $0 · Grant/award (A): 3,487 (derivative) @ $0 | EDGAR |
| 2023-12-13 | 4 | ADAMS ADRIAN — Director | Grant/award (A): 581 @ $0 · Grant/award (A): 3,487 (derivative) @ $0 | EDGAR |
| 2023-12-13 | 4 | Broadfoot Jill Marie — Director | Grant/award (A): 581 @ $0 · Grant/award (A): 3,487 (derivative) @ $0 | EDGAR |
| 2023-12-13 | 4 | WAN MARK A — Director | Grant/award (A): 581 @ $0 · Grant/award (A): 3,487 (derivative) @ $0 | EDGAR |
| 2023-12-13 | 4 | HOFFMAN STEPHEN J — Director | Grant/award (A): 581 @ $0 · Grant/award (A): 3,487 (derivative) @ $0 | EDGAR |
| 2023-09-11 | 4 | Angotti Vincent J. — Chief Executive Officer, Director | Purchase (P): 10,000 @ $0.80 | EDGAR |
| 2023-08-25 | 4 | Palmer Pamela P — Chief Medical Officer, Director | Sale (S): 9,514 @ $1.17 · Sale (S): 7,442 @ $1.09 | EDGAR |
| 2023-03-06 | 4 | Palmer Pamela P — Chief Medical Officer, Director | Tax withholding (F): 570 @ $1.31 | EDGAR |
| 2023-03-06 | 4 | ASADORIAN RAFFI — Chief Financial Officer | Tax withholding (F): 510 @ $1.31 | EDGAR |
| 2023-03-06 | 4 | Angotti Vincent J. — Chief Executive Officer, Director | Tax withholding (F): 1,703 @ $1.31 | EDGAR |
| 2023-03-06 | 4 | Dasu Badri N — Chief Engineering Officer | Tax withholding (F): 398 @ $1.31 | EDGAR |
Recent 8-K events — ACELRX PHARMACEUTICALS INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-16 | 8-K | 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2026-03-13 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-22 | 8-K | 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events | EDGAR |
| 2025-10-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ACRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →